TITLE

Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy

AUTHOR(S)
Angelberger, S.; Reinisch, W.; Dejaco, C.
PUB. DATE
September 2006
SOURCE
Gut;Sep2006, Vol. 55 Issue 9, p1364
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor discussing the case study of a patient whose pregnancy was preserved by intravenous ciclosporin treatment of fulminant ulcerative colitis is presented.
ACCESSION #
22184131

 

Related Articles

  • Response to Jackson et al. Tursi, Antonio; Papa, Alfredo // American Journal of Gastroenterology;Mar2011, Vol. 106 Issue 3, p547 

    A response by Antonio Tursi and Alfredo Papa to a letter to the editor regarding their article "Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study" in the...

  • Early aggressive therapy for severe extensive ulcerative colitis. De-Jun Cui; Stocchi, Luca // World Journal of Gastroenterology;9/7/2009, Vol. 15 Issue 33, p4218 

    The current ulcerative colitis (UC) treatment algorithm involves a step-up therapeutic strategy, mainly aiming at inducing and maintaining its clinical remission. Although this therapeutic strategy may seem to be cost-efficient and reduce the risk of side effects, recent trials and case reports...

  • Focusing on the medical needs can blind us to the full picture. Ryan, Bridget // Nursing Standard;1/13/2010, Vol. 24 Issue 19, p32 

    A letter to the editor is presented in response to the severe ulcerative colitis learning zone article by Mark Sephton in the December 16, 2009 issue.

  • RESPONSE TO OBSERVATIONS ON SEVERE ULCERATIVE COLITIS.  // Nursing Standard;1/20/2010, Vol. 24 Issue 20, p33 

    The article presents a response by author Mark Sephton to letters to the editor about his article concerning the management of patients with ulcerative colitis in the December 16, 2010 issue.

  • Mesalamine enema-induced exacerbation of ulcerative colitis. Bousseaden, A.; Ajana, F. Z.; Essamri, W.; Benelbarhdadi, I.; Afifi, R.; Benazzouz, M.; Essaid, A. // International Journal of Colorectal Disease;Nov2009, Vol. 24 Issue 11, p1359 

    A letter to the editor is presented regarding the exacerbation of chronic ulcerative colitis with oral or rectal mesalamine preparations.

  • VSL#3 and Remission in Active Ulcerative Colitis: Larger Studies Required. Jackson, Emma L.; Hamlin, P. John; Ford, Alexander C. // American Journal of Gastroenterology;Mar2011, Vol. 106 Issue 3, p547 

    A letter to the editor is presented in response to the article "Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL #3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study," by A. Tursi and colleagues in the 2010...

  • Controlled-release mesalamine maintains remission in ulcerative colitis.  // Modern Medicine;Jul95, Vol. 63 Issue 7, p52 

    Presents an abstract of the article titled `Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis,' by P. Miner, S. Hanauer, M. Robinson et al originally published in the February 1995 issue of `Digest of Diseases in Science.'

  • Soothe gut feelings. Munson, Marty; Yeykal, Teresa A. // Prevention;Aug94, Vol. 46 Issue 8, p36 

    States that new research suggests that `the patch' used by smokers may also be used to treat ulcerative colitis (UC). How it works is a bit of a mystery, but one theory suggests it may increase a natural anti-inflammatory hormone, called cortisol; Report in `New England Journal of Medicine,'...

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie, D. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p121 

    A review of the article "Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomized controlled trial," by D. Laharie and colleagues, which appeared in the 2012 issue of "Groupe d'Etudes Thérapeutiques des...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics